A self-described leading Asset Manager in Healthcare

HBM Partners

Saudi Company for Artificial Intelligence develops and implements artificial intelligence solutions across various sectors, including healthcare, sports, smart cities, and finance. It is a wholly-owned subsidiary of the Public Investment Fund and aims to position Saudi Arabia as a competitive hub for advanced technologies in alignment with Vision 2030.

Saudi Company for Artificial Intelligence

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Mineralys Therapeutics

Zosano Pharma

Nabriva Therapeutics

BioAtla

Galera Therapeutics

PTC Therapeutics

Pyxis Oncology

IVERIC bio

Acrivon Therapeutics

Ambrx

Aptinyx

Arcutis Biotherapeutics

Seer

Harmony Biosciences

Homology Medicines

Infinity Pharmaceuticals

Instil Bio

C4 Therapeutics

ChemoCentryx

IO Biotech

HBM Healthcare Investments AG

Metric
Company Name	HBM Partners	Saudi Company for Artificial Intelligence
Symbol
MSH ID	COM:HBMPARTNERS	SA:SCAI
Market	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Technology
Industry	Asset Management	Artificial Intelligence & Emerging Technologies
Country		SA
Stage
Employee Count	2
Website	hbmpartners.com	scai.sa
LinkedIn	hbm-healthcare-investments-ag
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

HBMP

COM:HBMPARTNERS

HBM Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue